Di Renzo MF - Search Results

1

MET overexpression turns human primary osteoblasts into osteosarcomas.

Patanè S, Avnet S, Coltella N, Costa B, Sponza S, Olivero M, Vigna E, Naldini L, Baldini N, Ferracini R, Corso S, Giordano S, Comoglio PM, Di Renzo MF. Patanè S, et al. Among authors: di renzo mf. Cancer Res. 2006 May 1;66(9):4750-7. doi: 10.1158/0008-5472.CAN-05-4422. Cancer Res. 2006. PMID: 16651428 Free article.

2

Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.

Lorenzato A, Olivero M, Patanè S, Rosso E, Oliaro A, Comoglio PM, Di Renzo MF. Lorenzato A, et al. Among authors: di renzo mf. Cancer Res. 2002 Dec 1;62(23):7025-30. Cancer Res. 2002. PMID: 12460923

3

Truncated RON tyrosine kinase drives tumor cell progression and abrogates cell-cell adhesion through E-cadherin transcriptional repression.

Bardella C, Costa B, Maggiora P, Patane' S, Olivero M, Ranzani GN, De Bortoli M, Comoglio PM, Di Renzo MF. Bardella C, et al. Among authors: di renzo mf. Cancer Res. 2004 Aug 1;64(15):5154-61. doi: 10.1158/0008-5472.CAN-04-0600. Cancer Res. 2004. PMID: 15289319

4

The therapeutic potential of hepatocyte growth factor to sensitize ovarian cancer cells to cisplatin and paclitaxel in vivo.

Bardella C, Dettori D, Olivero M, Coltella N, Mazzone M, Di Renzo MF. Bardella C, et al. Among authors: di renzo mf. Clin Cancer Res. 2007 Apr 1;13(7):2191-8. doi: 10.1158/1078-0432.CCR-06-1915. Clin Cancer Res. 2007. PMID: 17404103

5

The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.

Dani N, Olivero M, Mareschi K, van Duist MM, Miretti S, Cuvertino S, Patané S, Calogero R, Ferracini R, Scotlandi K, Fagioli F, Di Renzo MF. Dani N, et al. Among authors: di renzo mf. J Bone Miner Res. 2012 Jun;27(6):1322-34. doi: 10.1002/jbmr.1578. J Bone Miner Res. 2012. PMID: 22367914 Free article.

6

Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer.

Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR. Di Renzo MF, et al. Cancer Res. 1995 Mar 1;55(5):1129-38. Cancer Res. 1995. PMID: 7866999

7

Overexpression of the Met/HGF receptor in ovarian cancer.

Di Renzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P, Sismondi P, Comoglio PM. Di Renzo MF, et al. Int J Cancer. 1994 Sep 1;58(5):658-62. doi: 10.1002/ijc.2910580507. Int J Cancer. 1994. PMID: 8077049

8

Overexpression of the met/HGF receptor in renal cell carcinomas.

Natali PG, Prat M, Nicotra MR, Bigotti A, Olivero M, Comoglio PM, Di Renzo MF. Natali PG, et al. Among authors: di renzo mf. Int J Cancer. 1996 Jun 21;69(3):212-7. doi: 10.1002/(SICI)1097-0215(19960621)69:3<212::AID-IJC11>3.0.CO;2-9. Int J Cancer. 1996. PMID: 8682590

9

Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.

Olivero M, Valente G, Bardelli A, Longati P, Ferrero N, Cracco C, Terrone C, Rocca-Rossetti S, Comoglio PM, Di Renzo MF. Olivero M, et al. Among authors: di renzo mf. Int J Cancer. 1999 Aug 27;82(5):640-3. doi: 10.1002/(sici)1097-0215(19990827)82:5<640::aid-ijc4>3.0.co;2-6. Int J Cancer. 1999. PMID: 10417759

10

Hepatocyte growth factor sensitizes human ovarian carcinoma cell lines to paclitaxel and cisplatin.

Rasola A, Anguissola S, Ferrero N, Gramaglia D, Maffe A, Maggiora P, Comoglio PM, Di Renzo MF. Rasola A, et al. Among authors: di renzo mf. Cancer Res. 2004 Mar 1;64(5):1744-50. doi: 10.1158/0008-5472.can-03-2383. Cancer Res. 2004. PMID: 14996735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters